Delcath Systems Future Growth
Future criteria checks 5/6
Delcath Systems is forecast to grow earnings and revenue by 57.8% and 32.6% per annum respectively while EPS is expected to grow by 59.9% per annum.
Key information
57.8%
Earnings growth rate
59.9%
EPS growth rate
Medical Equipment earnings growth | 12.9% |
Revenue growth rate | 32.6% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Jan 2025 |
Recent future growth updates
Recent updates
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 31% Share Price Bounce
Jan 18Does Delcath Systems (NASDAQ:DCTH) Have A Healthy Balance Sheet?
Dec 19Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth
Nov 18Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 26% Share Price Bounce
Nov 01Delcath Systems, Inc.'s (NASDAQ:DCTH) 26% Jump Shows Its Popularity With Investors
Sep 10Is Delcath Systems (NASDAQ:DCTH) A Risky Investment?
Aug 27Delcath Systems, Inc. (NASDAQ:DCTH) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Aug 07Is Delcath Systems (NASDAQ:DCTH) Using Debt In A Risky Way?
Jan 15Delcath Systems (NASDAQ:DCTH) Has Debt But No Earnings; Should You Worry?
Oct 04Delcath Systems Q2 2022 Earnings Preview
Aug 05Delcath Systems to raise $5M in stock and warrants offering
Jul 18Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 152 | 38 | N/A | 75 | 5 |
12/31/2026 | 126 | 24 | 34 | 48 | 6 |
12/31/2025 | 78 | -3 | 2 | 16 | 6 |
12/31/2024 | 37 | -24 | -19 | -16 | 4 |
9/30/2024 | 23 | -34 | -26 | -26 | N/A |
6/30/2024 | 12 | -56 | -32 | -31 | N/A |
3/31/2024 | 5 | -50 | -37 | -37 | N/A |
12/31/2023 | 2 | -48 | -31 | -31 | N/A |
9/30/2023 | 2 | -45 | -30 | -30 | N/A |
6/30/2023 | 3 | -34 | -27 | -26 | N/A |
3/31/2023 | 3 | -37 | -23 | -23 | N/A |
12/31/2022 | 3 | -37 | -25 | -25 | N/A |
9/30/2022 | 4 | -33 | -24 | -24 | N/A |
6/30/2022 | 4 | -32 | -24 | -23 | N/A |
3/31/2022 | 4 | -28 | -25 | -24 | N/A |
12/31/2021 | 4 | -26 | -23 | -23 | N/A |
9/30/2021 | 2 | -27 | -22 | -22 | N/A |
6/30/2021 | 2 | -25 | -22 | -21 | N/A |
3/31/2021 | 2 | -23 | -23 | -22 | N/A |
12/31/2020 | 2 | -24 | -24 | -23 | N/A |
9/30/2020 | 2 | -5 | -24 | -23 | N/A |
6/30/2020 | 2 | -7 | -31 | -31 | N/A |
3/31/2020 | 2 | -9 | -26 | -26 | N/A |
12/31/2019 | 2 | -9 | -24 | -24 | N/A |
9/30/2019 | 2 | -32 | -20 | -20 | N/A |
6/30/2019 | 3 | -34 | -11 | -11 | N/A |
3/31/2019 | 3 | -34 | -11 | -11 | N/A |
12/31/2018 | 3 | -19 | -15 | -15 | N/A |
9/30/2018 | 3 | -28 | -17 | -17 | N/A |
6/30/2018 | 3 | -32 | N/A | -17 | N/A |
3/31/2018 | 3 | -27 | N/A | -18 | N/A |
12/31/2017 | 3 | -46 | N/A | -15 | N/A |
9/30/2017 | 3 | -34 | N/A | -15 | N/A |
6/30/2017 | 2 | -23 | N/A | -15 | N/A |
3/31/2017 | 2 | -27 | N/A | -14 | N/A |
12/31/2016 | 2 | -18 | N/A | -14 | N/A |
9/30/2016 | 2 | -15 | N/A | -15 | N/A |
6/30/2016 | 2 | -16 | N/A | -14 | N/A |
3/31/2016 | 2 | -13 | N/A | -16 | N/A |
12/31/2015 | 2 | -15 | N/A | -16 | N/A |
9/30/2015 | 2 | -13 | N/A | -15 | N/A |
6/30/2015 | 1 | -15 | N/A | -16 | N/A |
3/31/2015 | 1 | -16 | N/A | -15 | N/A |
12/31/2014 | 1 | -17 | N/A | -16 | N/A |
9/30/2014 | 1 | -19 | N/A | -18 | N/A |
6/30/2014 | 1 | -22 | N/A | -21 | N/A |
3/31/2014 | 1 | -23 | N/A | -28 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DCTH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: DCTH is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: DCTH is expected to become profitable in the next 3 years.
Revenue vs Market: DCTH's revenue (32.6% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: DCTH's revenue (32.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DCTH's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/02 20:04 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Delcath Systems, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Gorman | BTIG |
Marie Thibault | BTIG |
William Maughan | Canaccord Genuity |